Live Breaking News & Updates on Astellas Research

Stay updated with breaking news from Astellas research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Design Therapeutics Expands Board of Directors with Key


Design Therapeutics Expands Board of Directors with Key Appointments
June 07, 2021 16:05 ET
| Source:
Design Therapeutics, Inc.
Design Therapeutics, Inc.
Solana Beach, California, UNITED STATES
CARLSBAD, Calif., June 07, 2021 (GLOBE NEWSWIRE) Design Therapeutics, Inc. (Nasdaq: DSGN), a biotechnology company developing treatments for degenerative genetic disorders, today announced the appointments of industry veterans, Heather Behanna, Ph.D., principal of SR One, and Deepa Prasad, managing director of WestRiver Group, to its board of directors effective June 15, 2021.
“We are delighted to further strengthen the Design team with the appointments of both Heather and Deepa to our board of directors, who bring a wealth of experience and insights in corporate and financial strategy and biotechnology company growth,” said João Siffert, M.D., president and chief executive officer of Design Therapeutics. � ....

United States , Kellogg School , Alicia Davis , Heather Behanna , Coherus Biosciences , Deepa Prasad , University Of California , Design Therapeutics Inc , Feinberg Northwestern School Of Medicine , Weizmann Institute Of Science , Westriver Group , Tufts University , Astellas Research , California Hospital Association , Exchange Commission , Strategic Communications , Kellogg School Of Management At Northwestern University , Grant Funding Committee , Northwestern University , Capital Management , Second Genome , Entasis Therapeutics , Sofinnova Investments , Feinberg Northwestern School , Weizmann Institute , Blue Shield ,